Contents
On this page
- Distinction between statistical and clinical significance
- Comparison of interval bounds with the minimal clinically important difference (MCID)
- Statistical significance of trivial effects in large samples
- Promising but statistically inconclusive effects
- Recommendation for reporting
- Derivation of the minimal clinically important difference
- Worked numerical example
Academy · Research Data, Analytics & AI · CIs and Clinical Significance
Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference
A confidence interval permits a reader to compare both bounds of a result with a pre-specified minimal important difference, which a single P value cannot do. This comparison can reveal that a statistically significant result is clinically trivial, or that a clinically important result is statistically inconclusive.
Clinical significance concerns whether an effect is large enough to matter to a patient or clinician in practice, a question separate from statistical significance, which concerns only whether an effect is unlikely to have arisen by chance under a null hypothesis of exactly no difference. A confidence interval is the measure best suited to bridging the two because, unlike a single P value, it reports the full range of effect sizes with which the data are compatible; this range can then be compared directly against a pre-specified minimal clinically important difference (MCID) to judge whether the result is practically meaningful1.
Learning objectives
- Why statistical significance and clinical significance address two different questions
- The comparison of confidence interval bounds with a minimal clinically important difference
- A documented pattern in which very large sample sizes produce statistically significant but clinically trivial results
Common misconceptions
- “A statistically significant result (P < 0.05) is automatically a clinically significant one.” Statistical significance only indicates that an observed effect is unlikely under the null hypothesis; with a sufficiently large sample size, trivially small, clinically meaningless differences routinely reach statistical significance, which is why methodological guidance recommends checking a confidence interval's bounds against a minimal clinically important difference rather than relying on a P value alone.
Distinction between statistical and clinical significance
Statistical significance is a judgment about compatibility with a null hypothesis of exactly no effect, typically expressed through a P value falling below a conventional threshold such as 0.05. Clinical significance is an entirely separate judgment about whether the size of an effect is large enough to matter for patient care, treatment decisions, or quality of life1. Du Prel and colleagues, writing specifically to guide clinical researchers through this distinction, emphasize that a P value alone cannot answer the clinical-significance question because it carries no information about the magnitude of the effect, only about its compatibility with the null hypothesis; two results with very different clinical implications can share an identical P value1.
Comparison of interval bounds with the minimal clinically important difference (MCID)
The confidence interval addresses this limitation by reporting a full range of effect sizes compatible with the data, which can then be compared directly against a minimal clinically important difference defined before the analysis, that is, the smallest change in an outcome that patients or clinicians would regard as worth achieving2. If both the lower and upper bounds of the interval exceed the MCID, the result is both statistically and clinically significant with reasonable confidence; if both bounds fall below the MCID, the effect, even if statistically significant, is unlikely to be clinically important; and if the interval straddles the MCID, the result remains clinically inconclusive regardless of what its P value shows2. GRADE's imprecision domain formalizes this exact comparison as part of rating the overall certainty of a body of evidence, explicitly using the interval's position relative to decision-relevant thresholds rather than the P value3.
Statistical significance of trivial effects in large samples
Because statistical significance is partly a function of sample size, a sufficiently large study can detect an effect so small it has no practical relevance to patients and still report a P value well below 0.051. In this scenario, the confidence interval reveals what the P value obscures: a very large sample size produces a narrow confidence interval, and if that narrow interval lies entirely below the pre-specified MCID, the interval itself demonstrates that the statistically significant effect is too small to be clinically meaningful, a conclusion that the P value alone can neither support nor rule out2. This scenario clearly demonstrates why Cochrane and GRADE guidance both emphasize reporting and interpreting the interval, rather than the P value, when the question is whether a finding matters to patient care.
Promising but statistically inconclusive effects
The converse scenario is equally common and equally prone to misinterpretation: a small, early-phase study reports a point estimate well above the MCID, suggesting a clinically important benefit, but its confidence interval is wide because the sample size is small, and the interval's lower bound falls below the MCID or even below the null value1. Reporting such a result as "a clinically important effect was observed" overstates what the data support; the correct, more cautious framing is that the point estimate is promising but the interval shows the result remains statistically compatible with a trivial or absent effect, and a larger, confirmatory study is needed before the clinical significance can be regarded as established2. Gardner and Altman's original argument for favoring intervals over P values applies with equal force here: the interval, not the favorable-appearing point estimate alone, indicates to a reader how much confidence the data support4.
Recommendation for reporting
Methodological guidance converges on a specific recommendation: the pre-specified MCID should be stated explicitly in the methods section, the confidence interval should be reported alongside the point estimate and P value in the results, and the discussion should explicitly address where the interval's bounds lie relative to the MCID rather than leaving readers to make that comparison themselves13. Cochrane's guidance for summary of findings tables operationalizes this through the GRADE imprecision rating, which is intended to be legible to a reader who never opens the primary studies, precisely because the comparison of interval bounds against a decision threshold has already been made explicit by those closest to the data3.
Derivation of the minimal clinically important difference
A minimal clinically important difference is not an arbitrary round number chosen for convenience; validated methods for deriving one generally fall into two families, anchor-based approaches, which compare changes in a scale score against an external, clinically meaningful reference such as a patient's own global rating of improvement, and distribution-based approaches, which set the threshold relative to the measurement's own statistical variability, such as a fraction of its standard deviation1. Different valid methods applied to the same outcome measure can produce somewhat different MCID estimates, which is itself a reason to check which specific method and which specific patient population underlies a stated threshold before applying it to a new analysis, rather than treating a single published MCID figure as a fixed, universally transferable constant.
Worked numerical example
Consider a validated pain scale with a published MCID of 1.5 points, derived from an anchor-based method in a comparable patient population. A trial testing a new analgesic reports a mean difference of 2.1 points with a 95% confidence interval of 1.6 to 2.6; both bounds exceed the MCID, so the result supports a clinically important benefit with reasonable statistical confidence1. A second trial of a different analgesic reports an identical mean difference of 2.1 points but a wider interval of 0.4 to 3.8, because it enrolled fewer participants; this interval's lower bound falls well below the 1.5-point MCID, so despite the statistically significant and numerically identical point estimate, this second result should be described as inconclusive for clinical significance, pending a larger or more precise trial2. Both trials would likely report an identical P value for their respective comparisons against a null hypothesis of no difference at all, which is a further, concrete illustration of why the P value alone cannot do the job the interval, read against the MCID, is specifically built to do: it carries no information about where the plausible range of the true effect sits relative to a threshold that was never part of the null hypothesis the P value is testing in the first place5. Reporting both trials' confidence intervals side by side, rather than their shared P value, is the only way a reader can see this difference at a glance without redoing the underlying calculation themselves.
Extending this worked example further illustrates how the same logic applies when comparing a treatment against an active alternative rather than a placebo. Suppose a third trial compares the two analgesics directly and reports a mean difference of 0.3 points with a 95% confidence interval of -1.0 to 1.6; because both bounds fall well below the 1.5-point MCID, this result is informative in a different way than the first two trials, it supports a conclusion that the two drugs do not differ by a clinically important amount, provided the trial was designed with an appropriate equivalence or non-inferiority margin in mind rather than simply failing to detect a difference in a standard superiority analysis1. Laying all three intervals, the clearly favorable 1.6 to 2.6, the inconclusive 0.4 to 3.8, and the equivalence-supporting -1.0 to 1.6, on a single number line against the shared 1.5-point MCID threshold is a simple visual exercise that makes the difference between these three distinct clinical conclusions immediately apparent in a way that comparing three P values, or three point estimates, from the same three trials never could2. Such a combined display, showing the point estimate, interval and MCID threshold together, is increasingly recommended in reporting guidance because it allows a reader to make the clinical-significance judgment directly from the figure, without separately looking up the MCID or performing any recalculation3.
Key points
Key points
Statistical significance and clinical significance answer different questions. A confidence interval, rather than a P value, permits comparison of the full plausible range of an effect with a pre-specified minimal clinically important difference in both directions, identifying both overstated significance and understated promise, and thereby indicates whether a result is clinically meaningful.
Practical application
Practical application
- The minimal clinically important difference should be defined before results are examined. The smallest change in the outcome that would matter to patients or clinicians should be pre-specified, preferably at the protocol stage, before any analysis is conducted.
- Both bounds of the confidence interval should be compared with that threshold. The analyst should determine whether the lower and upper bounds lie on the same side of the MCID, which indicates whether the result is informative for clinical decision-making, straddles the threshold or falls entirely below it.
- Statistically significant but clinically trivial results should be identified explicitly. Where a narrow, statistically significant interval lies entirely below the MCID, this should be stated clearly in the results and discussion rather than presenting the significant P value as the principal finding.
Frequently asked questions
Yes, this can happen with a small or underpowered study: the point estimate may exceed a clinically important threshold, but the confidence interval is wide and includes both the null value and the MCID, making the result statistically inconclusive even though the observed point estimate appears clinically meaningful; additional data would be required to resolve the uncertainty.
It should ideally be defined by clinical experts and, where feasible, by patients, using validated methods for the specific outcome measure, and pre-specified before the study's results are known, to avoid the threshold being chosen in a way that favors a particular conclusion.
References
- du Prel JB, Hommel G, Rohrig B, Blettner M. Confidence interval or p-value? Part 4 of a series on evaluation of scientific publications. Deutsches Arzteblatt International. 2009;106(19):335-339. read 10 October 2026. View on Deutsches Arzteblatt International
- Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. Cochrane, 2024. read 10 October 2026. View on Cochrane Training
- Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence - imprecision. Journal of Clinical Epidemiology. 2011;64(12):1283-1293. read 10 October 2026. View on Journal of Clinical Epidemiology
- Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ. 1986;292(6522):746-750. read 10 October 2026. View on The BMJ
- Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. European Journal of Epidemiology. 2016;31(4):337-350. read 10 October 2026. View on European Journal of Epidemiology
- Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. The Lancet. 2005;365(9467):1348-1353. read 10 October 2026. View on The Lancet
- Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549. read 10 October 2026. View on The BMJ
- Altman DG, Bland JM. Statistics notes: Absence of evidence is not evidence of absence. BMJ. 1995;311(7003):485. read 10 October 2026. View on The BMJ
- Wasserstein RL, Lazar NA. The ASA Statement on p-Values: Context, Process, and Purpose. The American Statistician. 2016;70(2):129-133. read 10 October 2026. View on Taylor & Francis Online
- Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21(11):1539-1558. read 10 October 2026. View on PubMed
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference. Pubrica. https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/
Pubrica Academy. “Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference.” Pubrica, 10 Oct. 2026, pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/.
Pubrica Academy (2026) Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference. Pubrica. Available at: https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/ (Accessed: 15 October 2026).
Pubrica Academy. “Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference.” Pubrica. October 10, 2026. https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/
Pubrica Academy, ‘Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/> accessed 15 October 2026.
Pubrica Academy. Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/
Pubrica Academy, “Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/
@misc{/la_confidence_intervals_clinical_significance_2026,
author = {{Pubrica Academy}},
title = {Assessing Clinical Significance with Confidence Intervals and the Minimal Clinically Important Difference},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/assessment-of-clinical-significance-through-confidence-intervals/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Clinical Significance Assessment Template
This tool may be used to assess whether a statistically reported result is also clinically significant.
[ ] Defined a minimal clinically important difference before reviewing results, where possible [ ] Reported the confidence interval alongside the point estimate and P value [ ] Checked which side of the MCID both the lower and upper bounds fall on [ ] Flagged any statistically significant but clinically trivial result explicitly in the discussion [ ] Flagged any clinically promising but statistically inconclusive result as needing more data, not as negative
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica's clinical research review team checks reported confidence intervals against pre-specified minimal clinically important differences, flagging statistically significant but clinically trivial results before they go into a manuscript or report.